[1] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] Massachusetts Gen Hosp, Ctr Thorac Cancers, Boston, MA USA
[5] Univ Calif San Diego, Dept Med, Moores Canc Ctr, La Jolla, CA USA
[6] Natl Canc Ctr Hosp East, Thorac Oncol, Kashiwa, Chiba, Japan
[7] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands
[8] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[9] Seoul Natl Univ Hosp, Seoul, South Korea
[10] Univ Hosp Cologne, Dept Internal Med, Ctr Integrated Oncol, Cologne, Germany
[11] NCT Nat Zentrum Tumorerkrankungen, Dept Med Oncol, Heidelberg, Germany
[12] Royal Marsden Hosp NHS Fdn Trust, Dept Med, London, England
[13] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore
[14] Univ Washington, Thorac Head & Neck Med Oncol, Fred Hutchinson Canc Ctr, Sch Med, Seattle, WA USA
[15] Ctr Georges Francois Leclerc, Med Oncol, Dijon, France
[16] START Madrid FJD, Fdn Jimenez Diaz Hosp, Oncol, Madrid, Spain
[17] Hunan Canc Hosp, Oncol, Changsha, Peoples R China
[18] Turning Point Therapeut Inc, Bristol Myers Squibb Co, Clin Sci, San Diego, CA USA
[19] Bristol Myers Squibb, Clin Sci, Princeton, NJ USA
[20] Bristol Myers Squibb Co, Turning Point Therapeut Inc, Biostat, San Diego, CA USA
[21] Univ Paris Saclay, Gustave Roussy, Villejuif, France